All Discussions Tagged 'syringe' - QD Syringe Systems®2024-03-29T13:18:48Zhttps://qdsyringesystems.com/forum/topic/listForTag?tag=syringe&%3Bfeed=yes&%3Bxn_auth=no&feed=yes&xn_auth=noPreventing Needlestick Injuries in Health Care Settingstag:qdsyringesystems.com,2009-12-26:4605644:Topic:4022009-12-26T15:05:21.000ZChristopher Greenhttps://qdsyringesystems.com/profile/ChrisGreen
<b>Preventing Needlestick Injuries in Health Care Settings</b><br />
<br />
<p style="text-align:left"><img src="http://www.calchiefs.org/%5Citems%5CEMS_NIOSH_FDA_Logo.jpg"></img></p>
<br />
<b>WARNING!<br />
Health care workers who use or may be exposed to needles are at increased risk of needlestick injury. Such injuries can lead to serious or fatal infections with bloodborne pathogens such as hepatitis B virus, hepatitis C virus, or human immunodeficiency virus (HIV).</b><br />
<br />
<b>Employers of health care workers should implement the use of improved engineering controls to reduce…</b>
<b>Preventing Needlestick Injuries in Health Care Settings</b><br />
<br />
<p style="text-align:left"><img src="http://www.calchiefs.org/%5Citems%5CEMS_NIOSH_FDA_Logo.jpg"/></p>
<br />
<b>WARNING!<br />
Health care workers who use or may be exposed to needles are at increased risk of needlestick injury. Such injuries can lead to serious or fatal infections with bloodborne pathogens such as hepatitis B virus, hepatitis C virus, or human immunodeficiency virus (HIV).</b><br />
<br />
<b>Employers of health care workers should implement the use of improved engineering controls to reduce needlestick injuries:</b><br />
<br />
Eliminate the use of needles where safe and effective alternatives are available.<br />
<br />
Implement the use of devices with safety features and evaluate their use to determine which are most effective and acceptable.<br />
<br />
<b>Needlestick injuries can best be reduced when the use of improved engineering controls is incorporated into a comprehensive program involving workers. Employers should implement the following program elements:</b><br />
<br />
Analyze needlestick and other sharps-related injuries in your workplace to identify hazards and injury trends.<br />
<br />
Set priorities and strategies for prevention by examining local and national information about risk factors for needlestick injuries and successful intervention efforts.<br />
<br />
Ensure that health care workers are properly trained in the safe use and disposal of needles.<br />
<br />
Modify work practices that pose a needlestick injury hazard to make them safer.<br />
<br />
Promote safety awareness in the work environment.<br />
<br />
Establish procedures for and encourage the reporting and timely followup of all needlestick and other sharps-related injuries.<br />
<br />
Evaluate the effectiveness of prevention efforts and provide feedback on performance.<br />
<br />
________________________________________<br />
<br />
<a href="http://www.SafetySyringe.cc">www.SafetySyringe.cc</a><br />
<a href="http://www.GreenSyringe.com">www.GreenSyringe.com</a> Total Sales of Needles and Syringes to increase to $2 billion by 2010.tag:qdsyringesystems.com,2009-12-22:4605644:Topic:3172009-12-22T21:53:12.000ZChristopher Greenhttps://qdsyringesystems.com/profile/ChrisGreen
<p style="text-align:left"><img src="http://www.istockphoto.com/file_thumbview_approve/4859295/2/istockphoto_4859295-syringe-and-vials.jpg"></img></p>
The safety needles and syringes market represents a large and growing segment of the healthcare industry. In 1999, total sales of needles and syringes in the U.S. reached $759 million. This figure is expected to increase to $2 billion by 2010.<br />
<br />
According to the industry participants in Frost & Sullivan’s study, many believe that <b><u>safety needles and syringes</u></b> will eventually represent a majority of the needles and syringes market. The…
<p style="text-align:left"><img src="http://www.istockphoto.com/file_thumbview_approve/4859295/2/istockphoto_4859295-syringe-and-vials.jpg"/></p>
The safety needles and syringes market represents a large and growing segment of the healthcare industry. In 1999, total sales of needles and syringes in the U.S. reached $759 million. This figure is expected to increase to $2 billion by 2010.<br />
<br />
According to the industry participants in Frost & Sullivan’s study, many believe that <b><u>safety needles and syringes</u></b> will eventually represent a majority of the needles and syringes market. The market for safety needles and syringes is expected to grow from 23% in 1999 to a majority of the total needles and syringes market. The number of safety needles and syringes shipped is expected to grow from 900 million units in 1999 to over <b><u>10 billion units worldwide by 2010.</u></b><br />
<br />
<b>Investrend Communications, Inc estimates the number of needles and syringes sold worldwide to be <u>over 24 billion</u>.</b><br />
<br />
<b>The Cost of Change</b><br />
<br />
* The cost of needlestick injury follow-up in the U.S. per incident is around $3,000.<br />
* Accident follow ups cost the US medical industry $1.2 billion annually.<br />
* Annual treatment for contracted diseases in the US is $1.8 billion.<br />
* A total of $3 billion is spent annually in the US on needlestick injuries.<br />
* This is three times the amount spent on conventional syringes.<br />
* And almost 3 times the cost of converting to safety syringes.<br />
<br />
The balance of power is in transition, and the stage is set for the right product to gain more market share than has been achievable in recent history.<br />
<br />
Source:<br />
revolutionsmedical.com "Why Weren't You Just More Careful?"tag:qdsyringesystems.com,2009-12-20:4605644:Topic:3162009-12-20T16:17:05.000ZChristopher Greenhttps://qdsyringesystems.com/profile/ChrisGreen
<p><span class="font-size-4" style="color: #008000;"><b>"Why Weren't You Just More Careful?" What Does It Take to Avoid Occupational Exposure to HIV?</b></span></p>
<p></p>
<p style="text-align: left;"><img src="http://www.ivteam.com/wp-content/uploads/2009/03/hiv.jpg"></img></p>
<p>By Kristin White<br></br> <br></br> Healthcare workers can become infected with HIV in a variety of ways, but, according to the CDC, 80% of exposures occur through needle stick injuries. A worker stuck by a hollowbore needle contaminated with blood from an HIV-infected patient runs a…</p>
<p><span style="color: #008000;" class="font-size-4"><b>"Why Weren't You Just More Careful?" What Does It Take to Avoid Occupational Exposure to HIV?</b></span></p>
<p></p>
<p style="text-align: left;"><img src="http://www.ivteam.com/wp-content/uploads/2009/03/hiv.jpg"/></p>
<p>By Kristin White<br/> <br/> Healthcare workers can become infected with HIV in a variety of ways, but, according to the CDC, 80% of exposures occur through needle stick injuries. A worker stuck by a hollowbore needle contaminated with blood from an HIV-infected patient runs a 0.05% risk of becoming infected with the virus. "The risk isn't high for all health care workers, or significant for all health care workers—but for health care workers who are exposed to many HIV-infected patients, and/or have many percutaneous exposures, the problem is a very significant one," says James T. Curran, M.D., chief of CDC's AIDS Task Force. Getting stuck with a used needle is painful, frightening, and expensive. At the University of Virgina School of Medicine, Charlottesville, which has a comprehensive follow-up system, the average cost is $405. That is if the blood involved is HIVnegative. If it's HIV-positive, and the worker requires prophylactic AZT, cost begins to skyrocket. The physical and emotional costs are, of course, incalculable. The Prego Case In March 1990, Veronica Prego, M.D., who has AIDS, settled for $1,350,000 in a lawsuit brought against a New York City hospital where she had been an unpaid externe, with no medical insurance. Dr. Prego attributed her disease to exposure to HIV-contaminated needles and blamed the hospital and a physician co-worker who had, she said, left one contaminated needle in a heap of bed linen. Defense lawyers for the institution and the other physician argued that the carelessness was Dr. Prego's. Originally, the 32-year old Argentinean woman asked for a total of $175 million but accepted the smaller amount because payment of a higher judgment would have been delayed by appeals. Dr. Prego is not<br/> expected to live longer than a year. Nineteen other HIV-infected health care workers around the country have been waiting for the outcome of the Prego case to initiate similar lawsuits against their institutions. Authorities in the field believe as many as 200 workers have been infected<br/> on the job.<br/> <br/> <b>Universal Precautions:</b><br/> <br/> <b>A Partial Answer</b><br/> <br/> In this climate, preventing needle sticks is becoming a major occupational health priority for health care workers, but hospital rules, universal blood and body fluid precautions, and common sense are only partly effective. "Universal precautions would have prevented 40% of the 1500 needle stick injuries reported to us since 1983," says Jacquelyn Polder, R.N., M.P.H., coordinator of CDC's continuing study of occupational exposures to HIV. Universal precautions were not instituted nationwide until 1987, and even today, they are not followed consistently. For that matter, needle sticks are not reported consistently either, and therefore estimates of occupational exposures are probably low.<br/> <br/> <b>What Studies Indicate</b><br/> <br/> "Even within hospitals, needle sticks are underreported," says Ms. Polder. "People forget to report incidents, or don't want to be bothered with the paperwork, " she notes. Even so, the CDC's voluntary, passive study mirrors smaller and more rigorous studies at the University of California, San Francisco, where about 500 such injuries are reported yearly, and elsewhere. The statistics tell a consistent story. "Blood, in the health care setting, is risk. Period," David Henderson, M.D., of the National Institutes of Health told The New York Times in an interview on March 9, 1990. Dr.Henderson is in overall charge of infection control at the NIH Clinical Center in Bethesda. Marguerite Jackson, R.N., M.S., at the University of California, San Diego, has also studied occupational risks of HIV infection. "It's almost always associated with puncture wounds, " she says, "rather than the mucous membrane. When the numbers and the follow-up are complete, 1 person in 200 becomes infected, and will seroconvert within 6 months of the exposure." But many questions remain open such as the minimum amount of virus needed for infection. Looking at specific episodes is not necessarily very helpful, at this stage of the epidemic. "In a case report, there's no de-nominator," explains Ms. Jackson. "The individual may attribute HIV infection to the workplace in order to collect benefits for which they wouldn't be eligible if the infection came from sex or IV drug use. In evaluating a case report, you have to ask yourself whether the person's telling the truth, or is there another reason they don't want to share?<br/> <br/> ______________________________________________________________________________</p>
<p></p>
<p><a target="_blank" href="https://www.facebook.com/qdsyringe"><img class="align-full" src="http://storage.ning.com/topology/rest/1.0/file/get/3323499821?profile=original" width="64"/></a></p>
<p><a target="_blank" href="http://www.twitter.com/QDSyringe"><img class="align-full" src="http://storage.ning.com/topology/rest/1.0/file/get/3323499931?profile=original" width="64"/></a><a target="_blank" href="http://www.youtube.com/QDSyringeSystems"><img class="align-full" src="http://storage.ning.com/topology/rest/1.0/file/get/3323499995?profile=original" width="64"/></a><br/> <strong><span class="font-size-4"><span style="color: #ff0000;">Anesta</span>Web ::: Medical Product Division</span></strong></p>
<p><a href="http://www.qdss.co" target="_blank">www.QDSS.co</a><br/> <a href="http://www.SafetySyringe.cc">www.SafetySyringe.cc</a></p>
<p></p>
<p></p>
<p></p>
<p></p> Needlestick injuries beef up syringe markettag:qdsyringesystems.com,2009-12-05:4605644:Topic:722009-12-05T23:24:21.000ZChristopher Greenhttps://qdsyringesystems.com/profile/ChrisGreen
<b>Needlestick injuries beef up syringe market</b><br />
By Wai Lang Chu,<br />
<br />
<br />
According to a new report, the market for needle-free injection devices and safety syringes will exceed $2.49bn (€2.1bn) by 2009, buoyed on by the increase of incidences in needlestick injuries and high consumer demand for syringe alternatives.<br />
<br />
Biopharmaceutical research and development is sure to dramatically increase the number of injectable drugs coming to market over the next few years. While advanced drug delivery…
<b>Needlestick injuries beef up syringe market</b><br />
By Wai Lang Chu,<br />
<br />
<br />
According to a new report, the market for needle-free injection devices and safety syringes will exceed $2.49bn (€2.1bn) by 2009, buoyed on by the increase of incidences in needlestick injuries and high consumer demand for syringe alternatives.<br />
<br />
Biopharmaceutical research and development is sure to dramatically increase the number of injectable drugs coming to market over the next few years. While advanced drug delivery techniques continue to hold promise for unique methods of administration, the traditional injection is still the dominant paradigm.<br />
<br />
However, the staggering costs and intransigent safety problems associated with sharps, along with consumer demand and the move to alternate site care, are pushing for alternatives to traditional needles and syringes faster than advanced delivery technologies can come online.<br />
<br />
Annual needlestick injuries in the US alone average 600,000 to 1 million, and estimates indicate that as many as 80 per cent of the incidents could be prevented with the use of needle-free devices and safety syringes.<br />
<br />
The report, by market research firm Kalorama Information, details the costs associated with needlesticks-costing institutions over $3,000 per injury even when no infection occurs-coupled with other factors, such as patient fear of needles and the resulting lack of compliance, are strong enough drivers to grow the market by a compounded annual rate of 11 per cent over the next four years.<br />
<br />
Whether the devices are insulin pens for diabetics or mono-dose vaccine injectors, developing newer and safer ways of administering a wide variety of drug therapies is here to stay, even if such devices do come with a higher price tag.<br />
<br />
"Certainly the development, testing, regulatory approval, and eventual mass manufacturing of such devices is not cheap, yet the costs need to be continually weighed against the greater benefit to global health," said Joseph Constance, the report's author.<br />
<br />
"With newer injectable drugs coming to market and incidences of diseases requiring injectables, such as diabetes, escalating worldwide, the need for safer devices will continue to grow the market."<br />
<br />
The report explains that the alternative in the short term appears to be the growing industry of needle-free injection and safety-engineered syringes.<br />
<br />
These devices, ranging from simple sheathed safety needles to complex gas jet injection systems, are competing in a vigorous marketplace, some sectors of which are growing at an annual rate in excess of 20 per cent.<br />
<br />
Main market players in this arena include, Johnson & Johnson, Becton Dickinson and Kendall Healthcare, which is a Tyco International Company.<br />
<br />
While these companies are jostling for the number one position, there are an emerging number of companies who are seeing market niches go unmet.<br />
<br />
These companies include including Antares Pharma, Bioject, D'Antonio Consultants International, Retractable Technologies and Safety Syringes.<br />
<br />
The need for improved safety is clear especially as The Occupational Safety & Health Administration estimates that 8 million workers in the health care industry and related occupations are at risk of occupational exposure to bloodborne pathogens, including HIV, Hepatitis (Carried by at least 4 million Americans) and others. Accidental needlestick legislation points direction for syringe markettag:qdsyringesystems.com,2009-12-05:4605644:Topic:702009-12-05T23:21:00.000ZChristopher Greenhttps://qdsyringesystems.com/profile/ChrisGreen
<p><span class="font-size-5">There is a lot to be learned from history ::: This is when the ball started to roll!<br></br></span></p>
<p></p>
<p>Accidental needlestick legislation points direction for syringe market<br></br> Health Industry Today, July, 1999<br></br> <br></br> Anyone interested in catching a medical device groundswell near ground zero should be referred to safety needles and accidental sticks legislation. It's close to critical mass, it's going to get hotter, and it's about to affect the…</p>
<p><span class="font-size-5">There is a lot to be learned from history ::: This is when the ball started to roll!<br/></span></p>
<p></p>
<p>Accidental needlestick legislation points direction for syringe market<br/> Health Industry Today, July, 1999<br/> <br/> Anyone interested in catching a medical device groundswell near ground zero should be referred to safety needles and accidental sticks legislation. It's close to critical mass, it's going to get hotter, and it's about to affect the industry from the ground up.<br/> <br/> After nearly 20 years of bureaucratic contention, repeated warnings, and as many as one million accidental needle injuries per year, (resulting in thousands of hepatitis C infections and as many as 50 health care workers infected with AIDS annually), safety needles have caught the political eye of legislators.<br/> <br/> <br/> - In late 1998, California enacted a law that mandates safety needles in every health care facility throughout the state. The law requires full compliance by August 1, 1999. California was the first state to require the stickless syringes.<br/> <br/> - In March, 1999, Tennessee passed its own bill mandating safety needles.<br/> <br/> - In May, 1999, New Jersey's State Assembly passed a bill requiring mandatory safety needle use by health care facilities by a 77-0 vote.<br/> <br/> - Maryland governor Parris Glendening signed into law legislation to enforce the use of safety needles in his state one week after New Jersey passed its legislation.<br/> <br/> - In late May, a bill was introduced in Congress mandating the use of safety needles in all U.S. health care facilities. Rep. Pete Stark (D-Calif.) and Rep. Marge Roukema (R-N.J.) introduced the Health Care Worker Needle Stick Prevention Act of 1999.<br/> <br/> Similar legislation has been introduced in Florida, Massachusetts, Montana, Indiana, Illinois and Washington. In all, 20 states have passed, introduced or contemplated needle stick legislation designed to protect health care workers.</p> There are an estimated one million needle-sticks a yeartag:qdsyringesystems.com,2009-12-03:4605644:Topic:192009-12-03T02:19:35.000ZChristopher Greenhttps://qdsyringesystems.com/profile/ChrisGreen
Market Need<br />
There are an estimated one million needle-sticks (accidentally getting stuck with an exposed needle during a medical procedure) a year. This costs the medical industry over $3 billion annually to test and treat injured health care workers. The worldwide needle-syringe market is $1.5 billion (12 billion units).
Market Need<br />
There are an estimated one million needle-sticks (accidentally getting stuck with an exposed needle during a medical procedure) a year. This costs the medical industry over $3 billion annually to test and treat injured health care workers. The worldwide needle-syringe market is $1.5 billion (12 billion units). Analysis of safety syringe markettag:qdsyringesystems.com,2009-12-03:4605644:Topic:92009-12-03T02:08:19.000ZChristopher Greenhttps://qdsyringesystems.com/profile/ChrisGreen
One of the biggest challenges facing manufacturers of safety syringes in Europe is the lack of legislation on the use of these products in health care settings.<br />
<br />
Till date, none of the European countries has introduced clear rules governing the usage of safety devices or making their use mandatory. Some countries such as Germany have issued broad directives but these are meant to be guidelines and leave the final decision to the discretion of the purchasing agency.<br />
<br />
New analysis from Frost…
One of the biggest challenges facing manufacturers of safety syringes in Europe is the lack of legislation on the use of these products in health care settings.<br />
<br />
Till date, none of the European countries has introduced clear rules governing the usage of safety devices or making their use mandatory. Some countries such as Germany have issued broad directives but these are meant to be guidelines and leave the final decision to the discretion of the purchasing agency.<br />
<br />
New analysis from Frost & Sullivan reveals that the European safety syringes market generated a market revenue of USD 13 million in 2003 and is projected to double by 2010.<br />
<br />
Given that needlestick injuries amount to a staggering one million in Europe every year, and that 16 to 25 per cent of these are linked to the usage of single-use syringes, the market for safety syringes - which prevent needlestick injuries as well as discourage reuse - looks extremely promising.<br />
<br />
"A legislation that is sympathetic to the problems faced by the number of needlestick injuries occurring in Europe and the hazards of infection by over 20 pathogens that health workers face is needed," comments Frost & Sullivan Research Analyst Kavitha Ravikumar. "This will not only be socially lauded but also act as an effective driver to the safety syringes market."<br />
<br />
The Needlestick Prevention Act introduced in the United States represents the first true legislation towards mandating the use of safety engineered products in health care settings. This landmark legislation was introduced to address the growing concern of the health care industry for the safety of its employees. With the spread of blood-borne diseases such as AIDS and hepatitis, there is now, more than ever, an urgent need for safer devices that eliminate needlestick injuries.<br />
<br />
Huge health care expenditure on drug-related infections - over USD 900 million in the case of Spain and about USD 700 million in the case of Italy - can also be potentially controlled if syringe reuse and needle sharing become difficult due to distribution of safety syringes in place of the ordinary ones.<br />
<br />
The Needlestick Prevention Act has been instrumental in opening up a new market with considerable potential - the European market. While this market is still relatively very small, the increasing awareness of safety issues and the demands of health care workers for safer work environments are expected to help it grow significantly in the future.<br />
<br />
Meanwhile, in the absence of specific government legislation, safety syringe manufacturers must consider supporting movements lobbying for such laws and simultaneously work at raising awareness of safety issues and the drawbacks of not using safety devices.<br />
<br />
Currently, it is estimated that over 50 per cent of ordinary syringes have the potential to be replaced by safety products. This number is expected to rise to considerably in 2010 due to technological advances. Market penetration is also set to show substantial long-term increases from the presently low levels of 2.5 per cent.<br />
<br />
However, the high prices of safety syringes are likely to be a major constraint to market growth. These devices are perceived to be far too expensive at a time when almost all end-user markets are focused on cost-cutting.<br />
<br />
In spite of their proven advantages over ordinary syringes, adoption by healthcare agencies has not been very significant. Cost of new technology in a growing market combined with small-sized end-user markets is likely to continue to keep prices high.<br />
<br />
"Participants can consider applying for subsidies and exemptions on the welfare and citizen protection platform to bring down manufacturing costs, and consequently product prices," says Ms. Ravikumar. "Passing on the benefits of economies of scale can also help lower prices and drive demand for safety syringes."<br />
<br />
With syringes being a commodity market, there is a strong need to play up the innovation and technology benefits of these products. Companies must concentrate on the prestige and reputation associated with having safety products in their portfolios, particularly in premium and specialty health care areas.